PALBOCENT 125 MG
DESCRIPTION Palbocent Palbociclib 125 mg Capsules Incepta Pharmaceuticals Limited Indications Palbociclib is a kinase inhibitor indicated for the treatment of
PALBONIX 125 MG
DESCRIPTION Product Description: Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:
PONAXEN 15 MG
DESCRIPTION Generic Name Ponatinib Other Brand Name Ponaxen Packing 30 Form Tablet Strength 15mg, 45mg Manufacturer Everest Pharmaceuticals Ltd. COMPOSITION
ROXIBAC PLUS 250 _ 500 MG
Roxibac Plus Tablet Cefuroxime Axetil + Clavulanic Acid 250 mg+62.5 mg & 500Mg Julphar Bangladesh Ltd. Indications It is indicated for
SOFOXEN 400 MG
Sofoxen Tablet Sofosbuvir 400 mg Everest Pharmaceuticals Ltd. Indications Sofosbuvir is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor
TOFACENT 5 MG
DESCRIPTION Tofacent Tablet Tofacitinib 5 mg Incepta Pharmaceuticals Limited Indications Rheumatoid Arthritis: Tofacitinib is indicated for the treatment of adult
TREPMAC 90 MG
Trepmac Tablet Brigatinib 90 mg Genvio Pharma Ltd. Indications Brigatinib is indicated for the treatment of adult patients with anaplastic lymphoma
TWINVIR 90 MG
Twinvir Tablet Ledipasvir + Sofosbuvir 90 mg+400 mg Incepta Pharmaceuticals Ltd. Indications Ledipasvir and Sofosbuvir combination is indicated for the treatment
VELPANEX 400 _ 100 MG
Velpanex Tablet Sofosbuvir + Velpatasvir 400 mg+100 mg Everest Pharmaceuticals Ltd. Indications Sofosbuvir and Velpatasvir combination is indicated for the treatment
VOTRIENT 200 MG
VOTRIENT 200 MG/*54745756836*/